A combination of a liver stiffness measurement and clinical parameters may allow prediction of liver-related events such as hepatocellular carcinoma, hepatic decompensation, liver transplant and liver-related death in patients with metabolic dysfunction–associated steatotic liver disease, according to results from a new cohort study.
AUGUST 26, 2024